Showing results (341-350 of 454) with videos related to

Sort By:
Pageof 46
Journal of Immunological Methods|August 6, 1998
Carbohydrates engineered at antibody constant domains can be used for site-specific conjugation of drugs and chelatesZ Qu, R M Sharkey, H J Hansen, et al.
European Journal of Nuclear Medicine|January 1, 1992
Lymphoma imaging with a new technetium-99m labelled antibody, LL2S Murthy, R M Sharkey, D M Goldenberg, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 1, 1994
Detection of soft-tissue infections and osteomyelitis using a technetium-99m-labeled anti-granulocyte monoclonal antibody fragmentW Becker, J Bair, T Behr, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 30, 1999
The effects of domain deletion, glycosylation, and long IgG3 hinge on the biodistribution and serum stability properties of a humanized IgG1 immunoglobulin, hLL2, and its fragmentsS O Leung, Z Qu, H J Hansen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 29, 1999
Pharmacokinetics, dosimetry, and initial therapeutic results with 131I- and (111)In-/90Y-labeled humanized LL2 anti-CD22 monoclonal antibody in patients with relapsed, refractory non-Hodgkin's lymphomaM E Juweid, E Stadtmauer, G Hajjar, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 1, 1997
Regression of advanced refractory ovarian cancer treated with iodine-131-labeled anti-CEA monoclonal antibodyM Juweid, R M Sharkey, A Alavi, et al.
The Biochemical Journal|November 15, 1996
Internalization and catabolism of radiolabelled antibodies to the MHC class-II invariant chain by B-cell lymphomasH J Hansen, G L Ong, H Diril, et al.
International Journal of Cancer|July 29, 1997
Selection of radioimmunoconjugates for the therapy of well-established or micrometastatic colon carcinomaR M Sharkey, R D Blumenthal, T M Behr, et al.
Pageof 46